share_log

HC Wainwright & Co. Reiterates Buy on Kronos Bio, Maintains $9 Price Target

Benzinga ·  Nov 27, 2023 19:44

HC Wainwright & Co. analyst Robert Burns reiterates Kronos Bio (NASDAQ:KRON) with a Buy and maintains $9 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment